Talk:Tocilizumab
This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tocilizumab.
|
Untitled
[edit]Removed link to tocilizumab.com, which seems to be purely a collection of sponsored links, and not an official site. 81.107.41.207 (talk) 12:30, 21 March 2008 (UTC) Tocilizumab is great for halting arthritis. http://news.bbc.co.uk/2/hi/health/7692701.stm reports 47% of patients tested saw improvement over only 8% when methotrexate was taken alone. Karpinski (talk) 15:16, 27 October 2008 (UTC) —Preceding unsigned comment added by Karpinski (talk • contribs) 15:14, 27 October 2008 (UTC)
Five trials
[edit]The LITHE trial was reported extensively, but there have been several other phase III trials. http://arthritis.about.com/od/brms/a/actemra.htm sums them up. JFW | T@lk 10:25, 31 October 2008 (UTC)
"at 11 locations in China"
[edit]Is not really needed. It is in the reference. Doc James (talk · contribs · email) 23:11, 9 April 2020 (UTC)
Text
[edit]"This ability to counter cytokine release syndrome, also known as a cytokine storm, enables the use of Tocilizumab to treat the most extreme cases of COVID-19.[1]"
We need a proper reference. No we do not have evidence that this treats the most extreme cases... Doc James (talk · contribs · email) 02:53, 15 April 2020 (UTC)
References
- ^ Buchele, Mose (13 April 2020). "'I Felt Like Rip Van Winkle': One Of The 1st U.S. Doctors With COVID-19 Is Back Home". NPR. NPR. Retrieved 15 April 2020.